Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST.
暂无分享,去创建一个
A. Langer | G. Gensini | J. Egido | L. Blanco-Colio | J. Martín-Ventura | L. Leiter | A. Gaw | C. Farsang | P. Martineau | E. de Teresa